(Q46634145)

23 December 2017

title

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms (English)

1 reference

23 December 2017

0 references

1 reference

2

1 reference

23 December 2017

Paul Cumming

5

object named as

Paul Cumming

1 reference

23 December 2017

Yoshitaka Kumakura

1

object named as

Yoshitaka Kumakura

1 reference

23 December 2017

author name string

Erik H Danielsen

3

1 reference

23 December 2017

Søren Christensen

4

1 reference

23 December 2017

publication date

1 March 2006

1 reference

23 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

23 December 2017

volume

26

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

358-370

1 reference

23 December 2017

Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Design and construction of a realistic digital brain phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Loss of metabolites from monkey striatum during PET with FDOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Kinetics of the metabolism of four PET radioligands in living minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Functional effects of striatal dysfunction in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

A review of graphical methods for tracer studies and strategies to reduce bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Capillaries within compartments: microvascular interpretation of dynamic positron emission tomography data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

A nonparametric method for automatic correction of intensity nonuniformity in MRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

A reversible tracer analysis approach to the study of effective dopamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Modified regression model for the Logan plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

Apomorphine test for dopaminergic responsiveness: a dose assessment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-Dopa trapping in MPTP-induced parkinsonism in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600202

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600202

1 reference

23 December 2017

1 reference

23 December 2017